These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25310996)

  • 1. Bismuth(III) complexes derived from α-amino acids: the impact of hydrolysis and oxido-cluster formation on their activity against Helicobacter pylori.
    Busse M; Border E; Junk PC; Ferrero RL; Andrews PC
    Dalton Trans; 2014 Dec; 43(48):17980-90. PubMed ID: 25310996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Making bispirin: synthesis, structure and activity against Helicobacter pylori of bismuth(III) acetylsalicylate.
    Andrews PC; Blair VL; Ferrero RL; Junk PC; Kumar I
    Chem Commun (Camb); 2013 Apr; 49(28):2870-2. PubMed ID: 23450139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bismuth(III) benzohydroxamates: powerful anti-bacterial activity against Helicobacter pylori and hydrolysis to a unique Bi34 oxido-cluster [Bi34O22(BHA)22(H-BHA)14(DMSO)6].
    Pathak A; Blair VL; Ferrero RL; Mehring M; Andrews PC
    Chem Commun (Camb); 2014 Dec; 50(96):15232-4. PubMed ID: 25341969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents.
    Andrews PC; Blair VL; Ferrero RL; Junk PC; Kedzierski L; Peiris RM
    Dalton Trans; 2014 Jan; 43(3):1279-91. PubMed ID: 24190067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remarkable in vitro bactericidal activity of bismuth(III) sulfonates against Helicobacter pylori.
    Andrews PC; Busse M; Deacon GB; Ferrero RL; Junk PC; MacLellan JG; Vom A
    Dalton Trans; 2012 Oct; 41(38):11798-806. PubMed ID: 22903621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structural characterisation of bismuth(III) hydroxamates and their activity against Helicobacter pylori.
    Pathak A; Blair VL; Ferrero RL; Junk PC; Tabor RF; Andrews PC
    Dalton Trans; 2015 Oct; 44(38):16903-13. PubMed ID: 26352159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural influences on the activity of bismuth(III) indole-carboxylato complexes towards Helicobacter pylori and Leishmania.
    Pathak A; Blair VL; Ferrero RL; Kedzierski L; Andrews PC
    J Inorg Biochem; 2017 Dec; 177():266-275. PubMed ID: 28583712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bismuth coordination networks containing deferiprone: synthesis, characterisation, stability and antibacterial activity.
    Burrows AD; Jurcic M; Mahon MF; Pierrat S; Roffe GW; Windle HJ; Spencer J
    Dalton Trans; 2015 Aug; 44(31):13814-7. PubMed ID: 26172618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bismuth(III) complexes derived from non-steroidal anti-inflammatory drugs and their activity against Helicobacter pylori.
    Andrews PC; Ferrero RL; Junk PC; Kumar I; Luu Q; Nguyen K; Taylor JW
    Dalton Trans; 2010 Mar; 39(11):2861-8. PubMed ID: 20200713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterisation of bismuth(III) aminoarenesulfonate complexes and their powerful bactericidal activity against Helicobacter pylori.
    Busse M; Trinh I; Junk PC; Ferrero RL; Andrews PC
    Chemistry; 2013 Apr; 19(17):5264-75. PubMed ID: 23536213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metalloantibiotics: synthesis, characterization and antimicrobial evaluation of bismuth-fluoroquinolone complexes against Helicobacter pylori.
    Shaikh AR; Giridhar R; Megraud F; Yadav MR
    Acta Pharm; 2009 Sep; 59(3):259-71. PubMed ID: 19819823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and solution studies of phenylbismuth(III) sulfonate complexes and their activity against Helicobacter pylori.
    Andrews PC; Busse M; Deacon GB; Ferrero RL; Junk PC; Huynh KK; Kumar I; Maclellan JG
    Dalton Trans; 2010 Oct; 39(40):9633-41. PubMed ID: 20830402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization, and anti-Helicobacter pylori activity of Bi3+-Hericium erinaceus polysaccharide complex.
    Zhu Y; Chen Y; Li Q; Zhao T; Zhang M; Feng W; Takase M; Wu X; Zhou Z; Yang L; Wu X
    Carbohydr Polym; 2014 Sep; 110():231-7. PubMed ID: 24906751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel class of Bi(iii) hydroxamato complexes: synthesis, urease inhibitory activity and activity against H. pylori.
    Keogan DM; Twamley B; Fitzgerald-Hughes D; Griffith DM
    Dalton Trans; 2016 Jul; 45(27):11008-14. PubMed ID: 27314129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bismuth(III) 5-sulfosalicylate complexes: structure, solubility and activity against Helicobacter pylori.
    Andrews PC; Deacon GB; Ferrero RL; Junk PC; Karrar A; Kumar I; MacLellan JG
    Dalton Trans; 2009 Aug; (32):6377-84. PubMed ID: 19655072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antimicrobial effects and metabolomic footprinting of carboxyl-capped bismuth nanoparticles against Helicobacter pylori.
    Nazari P; Dowlatabadi-Bazaz R; Mofid MR; Pourmand MR; Daryani NE; Faramarzi MA; Sepehrizadeh Z; Shahverdi AR
    Appl Biochem Biotechnol; 2014 Jan; 172(2):570-9. PubMed ID: 24104691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and activity of some novel organo-metallic complexes against Helicobacter pylori.
    Nagarajan R; Mehta SI; Naik SR; Fabry W
    Arzneimittelforschung; 1999 Nov; 49(11):951-4. PubMed ID: 10604049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordination of thiosemicarbazones and bis(thiosemicarbazones) to bismuth(III) as a strategy for the design of metal-based antibacterial agents.
    Lessa JA; Reis DC; Da Silva JG; Paradizzi LT; da Silva NF; Carvalho Mde F; Siqueira SA; Beraldo H
    Chem Biodivers; 2012 Sep; 9(9):1955-66. PubMed ID: 22976983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homo- and heteroleptic bismuth(III/V) thiolates from N-heterocyclic thiones: synthesis, structure and anti-microbial activity.
    Luqman A; Blair VL; Brammananth R; Crellin PK; Coppel RL; Andrews PC
    Chemistry; 2014 Oct; 20(44):14362-77. PubMed ID: 25224757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific interactions of Bi(III) with the Cys-Xaa-Cys unit of a peptide sequence.
    Rowinska-Zyrek M; Valensin D; Szyrwiel L; Grzonka Z; Kozlowski H
    Dalton Trans; 2009 Nov; (42):9131-40. PubMed ID: 20449188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.